Nicholas Alexander Telischak, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Telischak’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A109575 · Current
Licensed to practise in California · since 2009 · expires 2027-04-30 · Dartmouth Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$54,396
Medicare paid this office $54,396 for 121 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 16 | $11,224 | $701 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 16 | $5,177 | $288 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 12 | $2,337 | $180 |
| Return visit (30+ min) | 23 | $2,283 | $88 |
| New patient visit (45+ min) | 20 | $2,274 | $114 |
See all 9 services
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 16 | $11,224 | $701 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 16 | $5,177 | $288 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 12 | $2,337 | $180 |
| Return visit (30+ min) | 23 | $2,283 | $88 |
| New patient visit (45+ min) | 20 | $2,274 | $114 |
| Return visit (30+ min) | 16 | $2,062 | $115 |
| Short return visit (20+ min) | 11 | $912 | $83 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 43 | $462 | $10 |
| Ultrasonic guidance for needle placement | 12 | $320 | $27 |
Who their Medicare patients are
121 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 20% · Women 55% · Also on Medicaid 30% · Health risk score 1.88. Above the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Stroke 46% · Diabetes 36% · Atrial fibrillation 35% · Chronic kidney disease 31% · Coronary heart disease 30% · Heart failure 28% · Depression 28% · Cancer 21% · Dementia 14% · COPD 12%.
The office billed $962,147, Medicare allowed $69,206 and paid $54,396; for 326 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 121 | 326 | 75 | 1.88 | $962,147 | $54,396 |
| 2023 | 125 | 406 | 74 | 1.86 | $990,640 | $61,517 |
| 2022 | 135 | 467 | 72 | 1.78 | $989,178 | $73,599 |
| 2021 | 168 | 584 | 73 | 1.60 | $1,130,616 | $83,174 |
| 2020 | 125 | 433 | 73 | 2.00 | $786,883 | $71,762 |
| 2019 | 155 | 524 | 76 | 1.82 | $713,707 | $63,951 |
| 2018 | 131 | 313 | 77 | 1.63 | $198,952 | $60,082 |
| 2017 | 163 | 406 | 75 | 1.35 | $239,418 | $69,057 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 23 | $8,357 | $334 |
| Return visit (30+ min) | 38 | $4,878 | $90 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 18 | $3,186 | $177 |
| New patient visit (45+ min) | 14 | $1,718 | $123 |
| Deep biopsy of bone using needle or trocar | 11 | $1,327 | $111 |
| Needle biopsy or removal of surface lymph nodes | 16 | $1,268 | $79 |
| Short return visit (20+ min) | 13 | $915 | $61 |
| Review by radiologist of image for insertion of material to block blood flow | 11 | $811 | $62 |
| Ultrasonic guidance for needle placement | 17 | $472 | $28 |
| Fluoroscopic guidance for needle placement | 11 | $300 | $25 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 44 | $213 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $176 | $11 |
2022: 15 services
| Occlusion of central nervous system or spinal cord artery | 18 | $20,279 | $922 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 28 | $8,628 | $298 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 22 | $3,874 | $176 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 12 | $3,445 | $265 |
| Return visit (30+ min) | 25 | $2,807 | $88 |
| Imaging of blood vessel | 19 | $2,443 | $79 |
| Insertion of tube into external neck artery for diagnosis or treatment with review by radiologist | 18 | $2,234 | $124 |
| Long return visit (40+ min) | 12 | $1,547 | $129 |
| Review by radiologist of image for insertion of material to block blood flow | 19 | $1,434 | $62 |
| New patient visit (45+ min) | 11 | $1,238 | $113 |
| Short return visit (20+ min) | 14 | $848 | $50 |
| Needle biopsy or removal of surface lymph nodes | 11 | $830 | $75 |
| New patient visit (30+ min) | 11 | $759 | $69 |
| Ultrasonic guidance for needle placement | 18 | $476 | $26 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 51 | $259 | $5 |
2021: 16 services
| Occlusion of central nervous system or spinal cord artery | 14 | $17,589 | $879 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 33 | $13,212 | $367 |
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 11 | $8,103 | $737 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 26 | $5,156 | $184 |
| Return visit (30+ min) | 22 | $2,646 | $91 |
| Insertion of tube into external neck artery for diagnosis or treatment with review by radiologist | 19 | $2,474 | $118 |
| New patient visit (45+ min) | 19 | $2,374 | $125 |
| Imaging of blood vessel | 13 | $2,230 | $80 |
| Deep biopsy of bone using needle or trocar | 18 | $2,189 | $122 |
| Short return visit (20+ min) | 21 | $1,544 | $62 |
| Review by radiologist of image for insertion of material to block blood flow | 14 | $1,204 | $63 |
| Needle biopsy or removal of surface lymph nodes | 15 | $999 | $67 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 80 | $998 | $11 |
| Ultrasonic guidance for needle placement | 25 | $715 | $29 |
| Fluoroscopic guidance for needle placement | 19 | $489 | $26 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $83 | $5 |
2020: 14 services
| Occlusion of central nervous system or spinal cord artery | 11 | $13,214 | $1,016 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 29 | $11,323 | $354 |
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 15 | $11,217 | $748 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 21 | $3,579 | $170 |
| Insertion of tube into external neck artery for diagnosis or treatment with review by radiologist | 14 | $1,735 | $124 |
| New patient visit (45+ min) | 14 | $1,534 | $110 |
| Deep biopsy of bone using needle or trocar | 11 | $1,328 | $121 |
| Return visit (30+ min) | 12 | $940 | $67 |
| Review by radiologist of image for insertion of material to block blood flow | 11 | $899 | $64 |
| Needle biopsy or removal of surface lymph nodes | 12 | $785 | $60 |
| Short return visit (20+ min) | 11 | $670 | $48 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $661 | $11 |
| Ultrasonic guidance for needle placement | 17 | $531 | $28 |
| Fluoroscopic guidance for needle placement | 11 | $290 | $26 |
2019: 9 services
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 23 | $9,287 | $371 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 21 | $4,472 | $203 |
| Insertion of tube into external neck artery for diagnosis or treatment with review by radiologist | 12 | $1,798 | $138 |
| Needle biopsy or removal of surface lymph nodes | 12 | $778 | $65 |
| 3d radiographic procedure with computerized image postprocessing | 13 | $484 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 40 | $448 | $11 |
| Ct scan head or brain without contrast | 12 | $443 | $37 |
| Ultrasonic guidance for needle placement | 14 | $404 | $29 |
| X-ray of chest, 1 view | 15 | $131 | $8 |
2018: 9 services
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 18 | $13,388 | $705 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 21 | $6,821 | $284 |
| Critical care, first 30-74 minutes | 20 | $4,660 | $194 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 17 | $3,685 | $184 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 26 | $3,088 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,160 | $180 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | $699 | $47 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $284 | $11 |
| Ultrasonic guidance for blood vessel access | 19 | $267 | $13 |
2017: 9 services
| Occlusion of central nervous system or spinal cord artery | 11 | $12,256 | $875 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 31 | $9,438 | $295 |
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 14 | $9,380 | $670 |
| Critical care, first 30-74 minutes | 21 | $8,026 | $196 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 32 | $5,871 | $178 |
| Review by radiologist of image for insertion of material to block blood flow | 13 | $950 | $59 |
| Ct scan head or brain without contrast | 25 | $924 | $37 |
| 3d radiographic procedure with computerized image postprocessing | 18 | $756 | $36 |
| Ultrasonic guidance for blood vessel access | 35 | $472 | $13 |
Money from drug and device companies
$29,183 in 2025
| 2025 | 9 | 92 | $23,965 | $29,183 |
| 2024 | 7 | 57 | $28,777 | $33,055 |
| 2023 | 8 | 67 | $24,600 | $27,671 |
| 2022 | 6 | 64 | $18,150 | $19,733 |
| 2021 | 5 | 89 | $24,276 | $27,817 |
| 2020 | 4 | 27 | $5,850 | $6,332 |
| 2019 | 5 | 30 | $3,500 | $4,380 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Synchro Select | $13,237 | 62 payments
|
| Route 92 Medical | None | $7,091 | 3 payments
|
| Medical Device Business Services | Emboguard | $5,224 | 6 payments
|
| Qapel Medical | None | $3,218 | 2 payments
|
| DePuy Synthes Sales | Trufill | $243 | 5 payments
|
| Imperative Care | Zoom Reperfusion Catheter | $60 | 2 payments
|
See all 85 published payments
| Stryker | Meals · 2025-12-30 | Evolve | $16 |
| Stryker | Meals · 2025-12-22 | Evolve | $19 |
| Imperative Care | Meals · 2025-12-11 | Zoom 7x Catheter | $29 |
| Stryker | Meals · 2025-12-10 | Evolve | $19 |
| Stryker | Meals · 2025-12-03 | Evolve | $23 |
| Stryker | Meals · 2025-11-24 | Evolve | $15 |
| Stryker | Consulting · 2025-11-21 | Na | $713 |
| Balt USA | Meals · 2025-11-19 | Carrier Delivery Catheter | $23 |
| Stryker | Meals · 2025-11-13 | Evolve | $20 |
| Stryker | Meals · 2025-11-05 | Evolve | $18 |
| Stryker | Meals · 2025-11-03 | Evolve | $17 |
| Medtronic | Meals · 2025-10-24 | Onyx 18 | $30 |
| Stryker | Meals · 2025-10-23 | Target | $34 |
| Stryker | Meals · 2025-10-16 | Target | $16 |
| Stryker | Meals · 2025-10-15 | Evolve | $27 |
| Balt USA | Meals · 2025-10-13 | Carrier Delivery Catheter | $17 |
| Medical Device Business Services | Meals · 2025-09-29 | Emboguard | $33 |
| Medical Device Business Services | Consulting · 2025-09-29 | Emboguard | $3,152 |
| Medical Device Business Services | Travel · 2025-09-29 | Emboguard | $939 |
| Medical Device Business Services | Travel · 2025-09-26 | Trufill | $300 |
| Medical Device Business Services | Travel · 2025-09-24 | Trufill | $300 |
| Stryker | Meals · 2025-09-18 | Evolve | $17 |
| Medical Device Business Services | Travel · 2025-09-05 | Trufill | $499 |
| Stryker | Meals · 2025-09-03 | Evolve | $19 |
| Stryker | Meals · 2025-08-28 | Surpass Evolve | $34 |
| Stryker | Meals · 2025-08-28 | Evolve | $19 |
| Imperative Care | Meals · 2025-08-27 | Zoom Reperfusion Catheter | $31 |
| Stryker | Meals · 2025-08-18 | Evolve | $17 |
| Stryker | Meals · 2025-08-11 | Evolve | $18 |
| DePuy Synthes Sales | Meals · 2025-08-06 | Trufill | $19 |
| Stryker | Meals · 2025-08-04 | Evolve | $19 |
| Stryker | Consulting · 2025-08-01 | None | $900 |
| Balt USA | Meals · 2025-08-01 | Carrier Delivery Catheter | $18 |
| Stryker | Meals · 2025-07-31 | Evolve | $23 |
| Stryker | Meals · 2025-07-31 | None | $22 |
| Stryker | Meals · 2025-07-31 | None | $15 |
| Stryker | Meals · 2025-07-30 | Evolve | $14 |
| Stryker | Meals · 2025-07-28 | Evolve | $24 |
| Stryker | Meals · 2025-07-17 | Evolve | $16 |
| DePuy Synthes Sales | Meals · 2025-07-14 | Trufill | $22 |
| Stryker | Meals · 2025-07-10 | Evolve | $17 |
| Stryker | Meals · 2025-07-07 | Evolve | $20 |
| Stryker | Meals · 2025-06-25 | Evolve | $23 |
| Stryker | Meals · 2025-06-24 | Surpass Evolve | $130 |
| Stryker | Meals · 2025-06-24 | Evolve | $15 |
| Stryker | Meals · 2025-06-24 | Evolve | $18 |
| MicroVention | Meals · 2025-06-12 | Stent | $22 |
| Stryker | Meals · 2025-06-12 | Evolve | $9 |
| Stryker | Consulting · 2025-06-06 | None | $2,700 |
| Stryker | Meals · 2025-06-06 | Evolve | $26 |
| Stryker | Meals · 2025-06-05 | Evolve | $21 |
| Stryker | Meals · 2025-06-02 | Evolve | $17 |
| Stryker | Consulting · 2025-05-30 | Synchro Select | $2,700 |
| Stryker | Consulting · 2025-05-30 | None | $1,350 |
| Stryker | Consulting · 2025-05-30 | Synchro Select | $3,600 |
| Stryker | Meals · 2025-05-28 | Evolve | $21 |
| Route 92 Medical | Travel · 2025-05-07 | None | $1,201 |
| Stryker | Meals · 2025-05-01 | Evolve | $25 |
| Stryker | Meals · 2025-04-30 | None | $38 |
| Stryker | Meals · 2025-04-30 | None | $10 |
| Stryker | Meals · 2025-04-28 | Evolve | $20 |
| Stryker | Meals · 2025-04-21 | Evolve | $17 |
| DePuy Synthes Sales | Meals · 2025-04-18 | N/A | $30 |
| Route 92 Medical | Consulting · 2025-04-04 | None | $5,700 |
| Stryker | Meals · 2025-03-27 | Evolve | $18 |
| Stryker | Meals · 2025-03-26 | Evolve | $20 |
| Stryker | Meals · 2025-03-24 | Evolve | $15 |
| Stryker | Meals · 2025-03-21 | Target | $136 |
| Stryker | Meals · 2025-03-17 | Evolve | $13 |
| Stryker | Meals · 2025-03-13 | Evolve | $5 |
| Stryker | Meals · 2025-03-11 | Evolve | $15 |
| Stryker | Meals · 2025-03-10 | Evolve | $19 |
| Qapel Medical | Consulting · 2025-03-04 | None | $3,150 |
| Stryker | Meals · 2025-02-28 | Evolve | $3 |
| Stryker | Meals · 2025-02-27 | Evolve | $11 |
| Stryker | Meals · 2025-02-26 | Evolve | $22 |
| Stryker | Meals · 2025-02-24 | Evolve | $16 |
| Stryker | Meals · 2025-02-10 | Evolve | $17 |
| DePuy Synthes Sales | Meals · 2025-02-04 | Trufill | $139 |
| Stryker | Meals · 2025-02-03 | Evolve | $15 |
| Qapel Medical | Meals · 2025-01-31 | None | $68 |
| DePuy Synthes Sales | Meals · 2025-01-30 | Trufill | $32 |
| Stryker | Meals · 2025-01-23 | None | $20 |
| Stryker | Meals · 2025-01-16 | Surpass Evolve | $21 |
| Route 92 Medical | Meals · 2025-01-15 | None | $190 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $33,055
| Medical Device Business Services | Emboguard | $11,575 | 8 payments
|
| Stryker | Tgs | $10,876 | 29 payments
|
| Route 92 Medical | 8f Base Camp Sheath System | $10,279 | 2 payments
|
| DePuy Synthes Sales | Trufill | $151 | 3 payments
|
| MicroVention | Azur Cx Detachable | $109 | 6 payments
|
| Qapel Medical | None | $49 | 1 payment
|
| Imperative Care | Zoom 88-T Large Distal Platform | $15 | 1 payment
|
2023: $27,671
| Stryker | Surpass Evolve | $18,415 | 46 payments
|
| Medtronic | Kyphon Express II Kyphopak Tray | $7,597 | 12 payments
|
| Neptune Medical | None | $1,500 | 1 payment
|
| Route 92 Medical | 8f Base Camp Sheath System | $75 | 1 payment
|
| MicroVention | Web Aneurysm Embolization System | $25 | 1 payment
|
| Penumbra | Red 72 | $21 | 1 payment
|
| Qapel Medical | None | $20 | 1 payment
|
| DePuy Synthes Sales | Trufill | $17 | 1 payment
|
2022: $19,733
| Stryker | Surpass Evolve | $15,671 | 38 payments
|
| Route 92 Medical | 8f Base Camp Sheath System | $2,035 | 2 payments
|
| MicroVention | Web Aneurysm Embolization System | $1,318 | 12 payments
|
| Siemens Medical Solutions USA | Artis Icono Biplane | $641 | 7 payments
|
| DePuy Synthes Sales | Prowler | $50 | 2 payments
|
| Penumbra | Benchmark | $18 | 1 payment
|
2021: $27,817
| Stryker | Surpass Evolve | $10,763 | 44 payments
|
| Medtronic | Osteocool Rf Ablation | $9,316 | 14 payments
|
| MicroVention | Web Aneurysm Embolization System | $7,692 | 29 payments
|
| DePuy Synthes Sales | Embotrap | $29 | 1 payment
|
| Penumbra | Penumbra System | $16 | 1 payment
|
2020: $6,332
| Stryker | Target | $4,415 | 8 payments
|
| Medtronic USA | Echelon | $1,681 | 13 payments
|
| MicroVention | Fred | $194 | 3 payments
|
| DePuy Synthes Sales | Embotrap II Revascularization Device | $42 | 3 payments
|
2019: $4,380
| Stryker | Trevo | $3,665 | 6 payments
|
| MicroVention | Web | $406 | 7 payments
|
| Medtronic USA | Solitaire | $274 | 14 payments
|
| Penumbra | Penumbra Coil 400 | $29 | 2 payments
|
| Relievant Medsystems | Intracept | $6 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1629244850
- Licence
- CA A109575California A109575: Current · expires 2027-04-30
- Trained
- Geisel School of Medicine at Dartmouth, 2008
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085N0700X (2085N0700X); Diagnostic radiology (2085R0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-05-07
- NPI last updated
- 2024-04-05
- NPI record certified
- 2024-04-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 504 Redwood Blvd, Novato, CA, 94947